Stay updated with breaking news from Journeymate Support Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(BPT) - Nearly 2,000 U.S. HCPs Have Prescribed RADICAVA® (edaravone) and RADICAVA ORS Since the Products Became Available in August 2017 and June 2022
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that nearly 2,000 people with amyotrophic lateral sclerosis (ALS) have received...
Radicava ORS (edaravone) oral suspension is now available for the treatment of adults with amyotrophic lateral sclerosis (ALS).
The U.S. Food and Drug Administration (FDA) has approved Mitsubishi Tanabe Pharma America's oral alternative to its own treatment for amyotrophic lateral sclerosis (ALS).
/PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the U.S. Food and Drug Administration (FDA) has approved RADICAVA ORS®...